tirzepatide monograph https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound PDB-101: Diabetes Mellitus: Diabetes Mellitus:

Together they bring decades of business experience, a deeply personal health journey, and a shared belief that people deserve better answers to their health issues than theyve been given

10.1126/sciadv.abq2422 457 VogtN

Stimulant medications (ADHD medications, certain weight loss drugs) add to heart rate through sympathetic activation

The effect of the GLP-1 analogue exenatide on functional connectivity within an NTSbased network in women with and without obesity

However, it's important to consult with a healthcare provider before starting any new supplement, particularly if you have underlying health conditions or are taking other medications

doi.org/10.1161/CIRCULATIONAHA.124.067676 6 Deer RR, Volpi E